EGFR+ UK has become a member of Lung Cancer Europe

We’re delighted to share that EGFR+ UK has become a member of Lung Cancer Europe (LuCE). This is an important step for us, as we join a community of organisations dedicated to improving the lives of those affected by lung cancer across Europe. 

Since our founding, our focus has always been on supporting individuals and families grappling with the challenges of EGFR-positive lung cancer. By becoming part of the LuCE family, we hope to learn from others, share our experiences, and work together to advocate for better care and treatment for all lung cancer patients. 

We’re grateful for the opportunity to contribute to this wider effort and look forward to the collaboration ahead.